A dedicated bipolar implantable cardioverter-defibrillator (ICD) lead for conduction system pacing (CSP) performed well in a first-in-human multicenter study. Placement of the novel UltiSynq CSP ICD ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Boston Scientific Corporation, a global medical technology leader, has received US Food and Drug Administration (FDA) approval to expand the indication for current-generation Ingevity+ Pacing Leads – ...
(RTTNews) - Boston Scientific Corporation (BSX) Tuesday said it received Food and Drug Administration's approval for the expanded indication of INGEVITY+ Pacing Leads to include conduction system ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for Boston Scientific’s pacemaker leads. The expanded indication ...
MARLBOROUGH, Mass. - Boston Scientific Corporation (NYSE: NYSE:BSX) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to expand the use of its INGEVITY+ ...
Study suggests men and women need distinct lipoprotein(a), or Lp(a), cutoffs to characterize their risk of heart disease. (Clinical Cardiology) Moderate coffee drinkers were at a relatively lower risk ...
Boston Scientific Corporation BSX recently received the Food and Drug Administration’s (FDA) approval to expand the indication for current-generation INGEVITY+ Pacing Leads. Expanded indication for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results